These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18202741)

  • 1. [Patients, patents and profits].
    Roland PC
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):205. PubMed ID: 18202741
    [No Abstract]   [Full Text] [Related]  

  • 2. [Free trade agreements make the drugs more expensive].
    Jeppsson A
    Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug costs threaten patent protection.
    Cimons M
    Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar.
    Sherrid P
    US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929
    [No Abstract]   [Full Text] [Related]  

  • 5. [The patent is "engine" in drug development].
    Bergström R
    Lakartidningen; 2008 Mar 5-11; 105(10):752. PubMed ID: 18422246
    [No Abstract]   [Full Text] [Related]  

  • 6. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 9. Handle with care.
    Macilwain C
    Nature; 2006 Apr; 440(7087):990-1. PubMed ID: 16625170
    [No Abstract]   [Full Text] [Related]  

  • 10. Going over the patent cliff.
    Schommer JC
    Minn Med; 2011 Oct; 94(10):42-3. PubMed ID: 23256283
    [No Abstract]   [Full Text] [Related]  

  • 11. Watch for these new generics.
    Consum Rep; 2012 May; 77(5):12. PubMed ID: 22641866
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives. CMS and Wall Street report...
    Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066
    [No Abstract]   [Full Text] [Related]  

  • 13. Protect pharmaceutical innovation.
    Musselwhite LW; Andrews J
    Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract]   [Full Text] [Related]  

  • 14. An ethical dilemma. Patents & profits v. access & affordability.
    Blasi AE
    J Leg Med; 2012 Jan; 33(1):115-28. PubMed ID: 22439710
    [No Abstract]   [Full Text] [Related]  

  • 15. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 16. [Patients, patents and profits].
    Haug C
    Tidsskr Nor Laegeforen; 2007 Nov; 127(22):2921. PubMed ID: 18026234
    [No Abstract]   [Full Text] [Related]  

  • 17. Protecting profits.
    Neroth P
    Lancet; 2004 Oct 2-8; 364(9441):1207-8. PubMed ID: 15470807
    [No Abstract]   [Full Text] [Related]  

  • 18. Generic drugs. Does inexpensive mean cheap?
    Dinsmoor RS
    Diabetes Self Manag; 2004; 21(1):8-10, 12. PubMed ID: 15025019
    [No Abstract]   [Full Text] [Related]  

  • 19. Generic drugs.
    Tuorto S; Hezel M; Marsh L; Eisenberg DP; Adusumilli PS
    Natl Med J India; 2005; 18(4):210-1. PubMed ID: 16252554
    [No Abstract]   [Full Text] [Related]  

  • 20. Long way down--pharmaceutical companies fear falling off 'patent cliff'.
    Sklan A
    Pharm Pat Anal; 2012 Jul; 1(3):240. PubMed ID: 24386667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.